• Home
  • Sitemap
  • Help
  • Technical Support
  • Contact
Toolbar - View Selection
 
Items 1 of 1
ALX-350-133 Revised 28-May-08
Topotecan . hydrochloride
Add to Clipboard
SYNONYMS 9-[(Dimethylamino)methyl]-10-hydroxy-(20S)-camptothecin . HCl
PRODUCT LINE Natural Products / Antibiotics
PRODUCT CATEGORY Natural Products - Topoisomerase Inhibitors
Ordering Information
Product Numbers: Format: Size: Unit Price: Quantity: Add To Cart
ALX-350-133-M001   1 mg 30.00 USD Add To Cart
ALX-350-133-M005   5 mg 90.00 USD Add To Cart
ALX-350-133-M025   25 mg 315.00 USD Add To Cart
Product Specification
FORMULA: C23H23N3O5 . HCl
MW: 421.5 . 36.5
CAS NUMBER: 119413-54-6
MERCK INDEX: 14: 9548
SOURCE/HOST: Semisynthetic.
PURITY: ≥98% (HPLC)
APPEARANCE: Light yellow to greenish powder.
SOLUBILITY: Soluble in water (1mg/ml) or methanol.
SHIPPING: AMBIENT
LONG TERM STORAGE: -20°C
HAZARD: TOXIC.

Product Description
Potent antitumor agent. Inhibitor of DNA-topoisomerase. Analog of (S)-(+)-camptothecin (Prod. No. ALX-350-015). Used in chemotherapy of several different cancers.
Product Specific Literature References
Synthesis of water-soluble (aminoalkyl)camptothecin analogues: inhibition of topoisomerase I and antitumor activity: W.D. Kingsbury, et al.; J. Med. Chem. 34, 98 (1991) Abstract
In vitro and in vivo activity of topotecan against human B-lineage acute lymphoblastic leukemia cells: F.M. Uckun, et al.; Blood 85, 2817 (1995) Abstract
Clinical status and optimal use of topotecan: C.H. Takimoto & S.G. Arbuck; Oncology (Williston Park) 11, 1635 (1997), Review Abstract
Topoisomerase I inhibition with topotecan: pharmacologic and clinical issues: B. Arun & E.P. Frenkel; Expert Opin. Pharmacother. 2, 491 (2001), Review Abstract
Topotecan for the treatment of small-cell lung cancer: S.J. Nicum & M.E. O´Brien; Expert Rev. Anticancer Ther. 7, 795 (2007) Abstract
Related Products
Further Categories Containing This Product:
Natural Products - Antitumor ReagentsAntitumor Agents (Enzyme Inhibitors)
 
 

Your items will be kept only for the duration of your visit.